Cerenis Therapeutics Holding SA (CEREN):企業の財務・戦略的SWOT分析

◆英語タイトル:Cerenis Therapeutics Holding SA (CEREN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15029
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company develops a portfolio of HDL therapies including HDL mimetics for the rapid regression of atherosclerotic plaque in high-risk patients such as patients with HDL deficiency, and post-ACS patients. It also develops drugs that increase HDL for patients with low number of HDL particles to treat atherosclerosis and related metabolic diseases. Cerenis works in partnership with other research and biotechnology companies for the development of HDL drug delivery products and technologies. The company has presence in France and the US. Cerenis is headquartered in Labege, France.

Cerenis Therapeutics Holding SA Key Recent Developments

Jan 24,2019: CERENIS Therapeutics: 2018 annual results and clinical update
Dec 19,2018: Cerenis Therapeutics names Richard Pasternak as CEO and Cyrille Tupin as deputy CEO
Oct 25,2018: Cerenis Therapeutics announces its cash position for Q3 2018 and highlights the progress made over the period and key perspectives for the end of 2018
Sep 10,2018: Cerenis Therapeutics announces 2018 half-year results
Jul 31,2018: Cerenis Announces the Appointment of Barbara Yanni to Its Board of Directors as an Independent Director

This comprehensive SWOT profile of Cerenis Therapeutics Holding SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cerenis Therapeutics Holding SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cerenis Therapeutics Holding SA – Key Information
Cerenis Therapeutics Holding SA – Overview
Cerenis Therapeutics Holding SA – Key Employees
Cerenis Therapeutics Holding SA – Key Employee Biographies
Cerenis Therapeutics Holding SA – Key Operational Heads
Cerenis Therapeutics Holding SA – Major Products and Services
Cerenis Therapeutics Holding SA – History
Cerenis Therapeutics Holding SA – Company Statement
Cerenis Therapeutics Holding SA – Locations And Subsidiaries
Cerenis Therapeutics Holding SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cerenis Therapeutics Holding SA – Business Description
Cerenis Therapeutics Holding SA – Corporate Strategy
Cerenis Therapeutics Holding SA – SWOT Analysis
SWOT Analysis – Overview
Cerenis Therapeutics Holding SA – Strengths
Cerenis Therapeutics Holding SA – Weaknesses
Cerenis Therapeutics Holding SA – Opportunities
Cerenis Therapeutics Holding SA – Threats
Cerenis Therapeutics Holding SA – Key Competitors

Section 3 – Company Financial Performance Charts

Cerenis Therapeutics Holding SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cerenis Therapeutics Holding SA, Key Information
Cerenis Therapeutics Holding SA, Key Ratios
Cerenis Therapeutics Holding SA, Share Data
Cerenis Therapeutics Holding SA, Major Products and Services
Cerenis Therapeutics Holding SA, History
Cerenis Therapeutics Holding SA, Key Employees
Cerenis Therapeutics Holding SA, Key Employee Biographies
Cerenis Therapeutics Holding SA, Key Operational Heads
Cerenis Therapeutics Holding SA, Other Locations
Cerenis Therapeutics Holding SA, Subsidiaries
Cerenis Therapeutics Holding SA, Key Manufacturing facilities
Cerenis Therapeutics Holding SA, Key Competitors
Cerenis Therapeutics Holding SA, SWOT Analysis
Cerenis Therapeutics Holding SA, Ratios based on current share price
Cerenis Therapeutics Holding SA, Annual Ratios
Cerenis Therapeutics Holding SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Cerenis Therapeutics Holding SA, Performance Chart
Cerenis Therapeutics Holding SA, Ratio Charts

★海外企業調査レポート[Cerenis Therapeutics Holding SA (CEREN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Great Wall Motor Co Ltd:企業の戦略・SWOT・財務情報
    Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Wintershall Holding GmbH:石油・ガス:M&Aディール及び事業提携情報
    Summary Wintershall Holding GmbH (Wintershall) explores for production of oil and natural gas. It operates as a subsidiary of BASF Group. The company holds expertise in conducting geological studies, geophysical measurements, seismic surveys, reservoir modeling, field development, onshore and offsho …
  • Coherex Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Coherex Medical Inc (Coherex), formerly Proximare, Inc is a subsidiary of Johnson & Johnson is a medical device company that designs, develops and markets catheter-based technologies for the treatment of certain structural heart defects. The company provides treatment of cardiovascular disea …
  • Telstra Corporation Limited:企業の戦略・SWOT・財務情報
    Telstra Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Telstra Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Japan Oil, Gas and Metals National Corp:企業の戦略的SWOT分析
    Japan Oil, Gas and Metals National Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Horizon Therapeutics PLC (HZNP):企業の財務・戦略的SWOT分析
    Horizon Therapeutics PLC (HZNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • CAB Incorporated:企業の戦略的SWOT分析
    CAB Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cementir Holding SpA:企業の戦略・SWOT・財務情報
    Cementir Holding SpA - Strategy, SWOT and Corporate Finance Report Summary Cementir Holding SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務分析
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Acxiom Corporation (ACXM):企業の財務・戦略的SWOT分析
    Acxiom Corporation (ACXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Freeborn-Mower Cooperative Services:企業の戦略的SWOT分析
    Freeborn-Mower Cooperative Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Baxter International Inc (BAX):企業の財務・戦略的SWOT分析
    Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Barnwell Industries Inc (BRN):企業の財務・戦略的SWOT分析
    Summary Barnwell Industries Inc (Barnwell) is a diversified company. The company's business activities include oil and natural gas, land investment, and contract drilling. Its oil and natural gas business offers exploration, development, production, and sales of oil and natural gas in Canada . Barnw …
  • Shima Seiki Mfg Ltd (6222):企業の財務・戦略的SWOT分析
    Shima Seiki Mfg Ltd (6222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Universal Biosensors Inc (UBI):企業の財務・戦略的SWOT分析
    Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Breas Medical AB:医療機器:M&Aディール及び事業提携情報
    Summary Breas Medical AB (Breas), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co Ltd, is a medical device company that manufactures and markets medical devices for anesthesia and respiratory markets. The company provides isleep and vivo products. It provides products such as isleep, vivo 3 …
  • Inox Wind Ltd (INOXWIND):企業の財務・戦略的SWOT分析
    Inox Wind Ltd (INOXWIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Welltower Inc:企業のM&A・事業提携・投資動向
    Welltower Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Welltower Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • EnBW Energie Baden-Wurttemberg AG (EBK):石油・ガス:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • Columbus Life Insurance Company:企業の戦略的SWOT分析
    Columbus Life Insurance Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆